AnaptysBio Inc (ANAB)
25.60
+0.34
(+1.35%)
USD |
NASDAQ |
May 15, 16:00
25.53
-0.07
(-0.27%)
After-Hours: 20:00
AnaptysBio Accounts Payable (Quarterly): 4.582M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.582M |
| December 31, 2023 | 4.698M |
| September 30, 2023 | 6.521M |
| June 30, 2023 | 4.761M |
| March 31, 2023 | 3.168M |
| December 31, 2022 | 2.784M |
| September 30, 2022 | 3.006M |
| June 30, 2022 | 1.587M |
| March 31, 2022 | 2.481M |
| December 31, 2021 | 1.741M |
| September 30, 2021 | 5.717M |
| June 30, 2021 | 4.103M |
| March 31, 2021 | 2.452M |
| December 31, 2020 | 4.217M |
| September 30, 2020 | 5.484M |
| June 30, 2020 | 6.289M |
| March 31, 2020 | 8.571M |
| December 31, 2019 | 16.24M |
| September 30, 2019 | 10.52M |
| Date | Value |
|---|---|
| June 30, 2019 | 10.92M |
| March 31, 2019 | 9.072M |
| December 31, 2018 | 5.443M |
| September 30, 2018 | 6.18M |
| June 30, 2018 | 4.426M |
| March 31, 2018 | 2.416M |
| December 31, 2017 | 2.323M |
| September 30, 2017 | 2.557M |
| June 30, 2017 | 3.724M |
| March 31, 2017 | 2.546M |
| December 31, 2016 | 2.278M |
| September 30, 2016 | 1.44M |
| June 30, 2016 | 2.06M |
| March 31, 2016 | 0.663M |
| December 31, 2015 | 1.521M |
| September 30, 2015 | 1.561M |
| June 30, 2015 | 0.765M |
| December 31, 2014 | 0.415M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.587M
Minimum
Jun 2022
16.24M
Maximum
Dec 2019
5.492M
Average
4.64M
Median
Accounts Payable (Quarterly) Benchmarks
| XOMA Corp | 1.515M |
| Fate Therapeutics Inc | 6.765M |
| Ocular Therapeutix Inc | 6.453M |
| Apellis Pharmaceuticals Inc | 26.79M |
| Sutro Biopharma Inc | 7.511M |